The inflammatory bowel disease treatment market is likely to grow at a 2.5% CAGR between 2018- 2023, according to the new report by Market Research Future (MRFR). Inflammatory bowel disease or IBD is caused when the immune system attacks harmless bacteria, virus, or foods in the intestine. The IBD treated helps reduce the inflammation, which triggers the signs and symptoms.
Various factors are propelling the global inflammatory bowel disease treatment market growth. According to the new MRFR report, such factors include burgeoning popularity of probiotic and prebiotic foods, rising number of drugs in clinical trials, growing cases of depression and anxiety, initiatives by the government for R&D on the discovery of novel drugs, advancements in medical technology, and rising patient pool.
On the contrary, strict drug regulatory policies, unsatisfactory effectiveness of treatments, the effect of the COVID-19 pandemic, and high capital investment needed for drug discovery are factors that may limit the global inflammatory bowel disease treatment market growth over the forecast period.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6266
Key Players
Key players profiled in the global inflammatory bowel disease treatment market report include Allergan plc, Pfizer Inc., Biogen Inc., Takeda Pharmaceutical Company Limited, UCB Inc, AbbVie, Inc., Alkem Laboratories Limited, Janssen Biotech, Inc., Novartis AG, Valeant Pharmaceuticals International, and Abbott Laboratories.
Segmentation
The MRFR report gives an inclusive segmental analysis of the global inflammatory bowel disease treatment market report based on end user, distribution channel, disease indication, and drug class.
- By Drug Class, the global inflammatory bowel disease treatment market is segmented into corticosteroids, immunomodulators, aminosalicylates, and TNF inhibitors. Of these, the aminosalicylates segment will lead the market over the forecast period.
- By Disease Indication, the global inflammatory bowel disease treatment market is segmented into Crohn’s disease and ulcerative colitis. Of these, the Crohn’s disease segment will dominate the market over the forecast period.
- By Distribution Channel, the global inflammatory bowel disease treatment market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. Of these, the hospital pharmacy segment will have a major share in the market over the forecast period.
- By End user, the global inflammatory bowel disease treatment market is segmented into hospitals & clinics, & others. Among these, hospitals & clinics will have lions share over the forecast period.
Regional Analysis
Based on the region, the market has been segmented into the Americas (North America and Latin America), Europe, Asia-Pacific (APAC), and the Middle East & Africa (MEA).
Americas is expected to account for the largest inflammatory bowel disease treatment market share. The developed infrastructure in the region is likely to improve the growth of the inflammatory bowel disease treatment market over the review period. Consequently, increasing per capita income along with the rising healthcare expenditure is expected to contribute to the market growth in the Americas over the forecast period. Moreover, the increasing prevalence of anxiety and gluten allergies and consumer inclination towards junk food have led to the growing number of patients suffering from inflammatory bowel disease in the region. Furthermore, the presence of key market players, rising health awareness among consumers, and the established healthcare sector are significant factors influencing the market growth.
Europe was the second-largest region in the inflammatory bowel disease treatment market. The European market is expected to display steady growth during the forecast period owing to the increasing prevalence of inflammatory bowel disease, unhealthy lifestyle habits, the rising rate of alcohol abuse, and the growing incidence of stress disorders, anxiety, and depression among adults. Additionally, factors such as increasing initiatives by the governments and increased funding for research, the expansion of advanced medical treatment options, and convenience of favorable reimbursement policies are likely to drive the growth of the market for inflammatory bowel disease treatment in Europe over the review period.
Get Access Full Report @ https://www.marketresearchfuture.com/reports/inflammatory-bowel-disease-treatment-market-6266
Asia-Pacific is anticipated as the fastest-growing inflammatory bowel disease treatment market with an exponential rise in the patient population. Developing countries such as Japan and China are expected to be the largest markets for inflammatory bowel disease treatment in Asia-Pacific. The rising prevalence of stress disorders, anxiety, and depression among adults along with the increasing substance abuse of alcohol and the sedentary lifestyles of consumers are expected to result in an increase in the patient pool, consequently fueling the need for treatment drugs.
The inflammatory bowel disease treatment market in the Middle East & Africa is estimated to witness the lowest growth rate and the smallest market share over the review period, owing to a lack of awareness about the disease, restricted access to and accessibility of treatment facilities, and lesser prevalence of the disorder in the region. However, the market share is expected to be majorly contributed by the middle eastern developing countries such as Kuwait, UAE, and Saudi Arabia.
Dietary Supplements in the Age of Personalized Nutrition Market Information: Product Category (Vitamins, Herbs & Botanicals, Others), Application (Lifestyle Diseases, Inherited Disease and Others), Gender, Dosage Form (Tablets, Capsules, Others) and End-User – Global Forecast till 2027Market Overview:In recent years, the dietary supplement market has witnessed tremendous growth.
The major factors influencing the growth of the market include rapid diversification and rising prevalence of various lifestyle diseases worldwide, rising approval from government bodies, growing awareness, and screening for diabetes mellitus, rise in research funding for diagnosis and treatment of these conditions.
Furthermore, increasing government healthcare expenditure for the welfare of the population, has spurred the growth of this market.
According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending is likely to increase 5.8% reaching USD 3.2 trillion.
Since 2016, the healthcare spending in North America has been increased.
Therefore, growing healthcare expenditure.Increasing incidence of diseases due to sedentary lifestyle and a lack of balanced diet has majorly influenced the growth of the market.
The insulin delivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc.
The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025.
Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes.
According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030.
Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period.
However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.Request a Sample Copy of the Global Insulin Delivery Devices Market Research Report @ www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market/request/rs1Further Key Findings from the Study Suggest:The insulin pens segment was the largest revenue-generating category of this market in 2015.
According to IMARC Group latest report titled” Oleoresin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is currently witnessing strong growth.
The global Oleoresin Market share to exhibit moderate growth during the next five years.
It prevents microbial contamination and provides heat stability, longer shelf life, and cost-efficiency.
Oleoresin is also used to prepare medicines, soaps, candles, and hair lotions around the world.Get a sample copy of this Report: https://www.imarcgroup.com/oyster-market/requestsampleAs the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.At present, there is an increase in the consumption of ready-to-eat (RTE) and fast-food items worldwide on account of sedentary lifestyles and inflating income levels.
Furthermore, the rising prevalence of gastrointestinal diseases among individuals is favorably influencing the product demand due to its anti-inflammatory and antioxidant properties.
The market is also driven by the considerably expanding agriculture sector, wherein oleoresin is used as a natural colorant.View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oleoresin-marketCompetitive Landscape with Key players:The report has also analysed the competitive landscape of the market with some of the key players being.Akay Natural Ingredients Private LimitedAmbe Phytoextracts Pvt.
Market Overview-The global injectable reproductive hormone market size is projected to grow monumentally in the upcoming years.
The rising infertility rates across the growing population are estimated to foster the market growth in the future.Request a Sample Copy of the Research ReportCOVID-19 Impact-The injectable reproductive hormone market has witnessed a negative impact amid the COVID-19 pandemic.
The shift of various clinics and healthcare facilities to accommodate coronavirus positive patients has impacted market growth.
Additionally, lockdowns and curfews imposed by governments of several nations resulted in disrupted supply chain networks which further aggravated the situation.
Based on applications, the market is fragmented into private dysfunction, menstruation disorders, contraception, infertility treatment, and others.
Geographically, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East& Africa.Report Coverage-The report highlights the key emerging trends for major countries.The report illustrates the latest technological advancements in the market.The report gives valuable insights into the regulatory scenarios of the prospected market.The report envisages Porters’ Five Forces Analysis for an infallible prediction.The report highlights critical developments like acquisitions, mergers, and partnerships.Quick Buy Injectable Reproductive Hormone MarketDrivers & Restraints-Ability to Prevent Pregnancies will Magnify Market GrowthReproductive hormones are used to treat various medical disorders.
Latest Patient Monitoring Device Market Report published by value market research, it provides a comprehensive market analysis which includes market size, share, value, growth, trends during forecast period 2020-2026 along with strategic development of the key player with their market share.
Further, the market has been bifurcated into sub-segments with regional and country market with in-depth analysis.This research report also includes profiles of major companies operating in the global market.
According to the research study by World Health Organization, it is estimated that 17.9 million people died from cardiovascular diseases in 2016 globally.
Two out of three people in retirement age are anticipated to suffer from two chronic conditions, according to the study by World Health Organization.Growing frequency of chronic and cardiovascular diseases is attributed to the aging society coupled with change in lifestyle preferences including smoking, alcohol consumption, unhealthy diet and sedentary lifestyles.
WHO research reveals that total cardiovascular disease population is expected to increase in the future, if no actions are taken to inhibit the increasing chronic disease cases.
However, high cost of these technologies negatively impacts the market progression.
Interventional Neurology Market InsightThe global interventional neurology market is expected to expand at a strong 7.8% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The report presents a complete picture of the global interventional neurology market to readers, including a detailed overview of the market’s historical growth trajectory and present condition in order to present forecasts for the market’s likely movement over the coming years.
The use of minimally invasive, image-guided techniques in the interventional neurology field is a major factor acting on the global interventional neurology market.
The use of minimally invasive techniques is expected to grow in the coming years thanks to the growing awareness about their benefits over conventional techniques.
Further research and development in the field of minimally invasive interventional neurology, leading to more techniques and improvements in existing techniques, is also likely in the coming years due to the growing awareness about minimally invasive interventional neurology techniques and the growing demand for minimally invasive techniques from patients.The increasing incidence of neurological conditions such as stroke is likely to be a major driver for the interventional neurology market over the forecast period.
Environmental factors such as the increased stress associated with living in urban environments and the increasing prevalence of sedentary lifestyles are also likely to play a part in the increasing prevalence of neurological disorders in the coming years, leading to a growing demand from the interventional neurology market.Interventional Neurology Market Competitive Analysis:Leading players in the global interventional neurology market include Cook Medical, B. Braun Melsungen AG, W. L. Gore & Associates Inc., Merit Medical Systems Inc., Microport Scientific Corporation, Penumbra Inc., Terumo Corporation, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, and Abbott Laboratories.Major players in the interventional neurology market are likely to focus on the development of more capable minimally invasive techniques in the coming years.
